Patients underwent electrocoagulation ablation therapy and were placed on high dose proton pump inhibitors (acid suppressors). Complete eradication of Barrett’s esophagus was achieved between one and five sessions. The researchers found 95 percent of patients had no recurrence of Barrett’s esophagus after initial ablation, and no adenocarcinoma or high-grade dysplasia of the esophagus developed in any of the patients.
The authors conclude that multipolar electrocoagulation is a safe, effective technique for ablating Barrett’s esophagus over the long term.
Read the ASGE release on Barrett’s esophagus (pdf).
Read more coverage on GI issues:
– Office Desk Jobs Double Colon Cancer Risk
– Local Washington Health Board Reverses Approval of Colonoscopy Campaign
– Coverage of Preventive Services Under New Healthcare Law Causing Confusion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
